澳大利亚皮肤癌转诊与会诊中使用远程皮肤镜的成本效益
该成本效益分析基于澳大利亚初级保健决策模型,比较远程皮肤镜转诊(含数字皮肤镜图像的电子转诊)与常规护理(书面转诊信)对疑似皮肤癌的专科皮肤科医生审核。结果显示远程皮肤镜转诊平均临床解决时间为9天,常规护理为35天(差值26天,95%可信区间13-38天);人均成本远程皮肤镜转诊为318.39澳元,常规护理为263.75澳元,差值54.64澳元(95%可信区间22.69-97.35澳元);每节省一天临床解决时间的增量成本为2.10澳元(95%可信区间0.87-5.29澳元)。
要点
- 远程皮肤镜转诊平均临床解决时间9天,常规护理35天,差值26天(95%可信区间13-38天)。
- 人均成本远程皮肤镜转诊318.39澳元,常规护理263.75澳元,差值54.64澳元(95%可信区间22.69-97.35澳元)。
- 每节省一天临床解决时间的增量成本为2.10澳元(95%可信区间0.87-5.29澳元)。
核心结论
- 在澳大利亚使用远程皮肤镜进行皮肤癌转诊和分诊平均每例额外花费54.64澳元,但临床解决时间比常规护理提前26天。
- 实施建议取决于澳大利亚卫生系统决策者对降低成本或加速临床解决的偏好。
- 关于加速临床解决的临床意义及其对患者重要性的进一步研究可为澳大利亚环境下的实施建议提供信息。
研究设计与样本
- 成本效益分析,使用澳大利亚初级保健的决策分析模型,基于公开可用数据。
- 比较远程皮肤镜转诊(含数字皮肤镜图像的电子转诊)与常规护理(书面转诊信)对疑似皮肤癌的专科皮肤科医生审核的成本。
- 进行概率敏感性分析以检查主要结果的不确定性。
主要发现
- 远程皮肤镜转诊的平均临床解决时间为9天(范围1-50天),常规护理为35天(范围0-138天),差值26天(95%可信区间13-38天)。
- 远程皮肤镜转诊的估计平均成本为318.39澳元,常规护理为263.75澳元,人均成本差值54.64澳元(95%可信区间22.69-97.35澳元)。
- 每节省一天临床解决时间的增量成本为2.10澳元(95%可信区间0.87-5.29澳元)。
关键数值与推荐
- 临床解决定义为皮肤科医生诊断或全科医生切除。
- 远程皮肤镜转诊平均临床解决时间9天(范围1-50天) vs 常规护理35天(范围0-138天),差值26天(95%可信区间13-38天)。
- 人均成本远程皮肤镜转诊318.39澳元 vs 常规护理263.75澳元,差值54.64澳元(95%可信区间22.69-97.35澳元)。
- 每节省一天临床解决时间的增量成本2.10澳元(95%可信区间0.87-5.29澳元)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 进一步研究围绕加速临床解决的临床意义及其对患者的重要性可为澳大利亚环境下的实施建议提供信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: International literature has shown that teledermoscopy referral may be a viable method for skin cancer referral; however, no economic investigations have occurred in Australia. OBJECTIVE: To assess the cost-effectiveness of teledermoscopy as a referral mechanism for skin cancer diagnosis and management in Australia. DESIGN, SETTING, AND PARTICIPANTS: Cost-effectiveness analysis using a decision-analytic model of Australian primary care, informed by publicly available data. INTERVENTIONS: We compared the costs of teledermoscopy referral (electronic referral containing digital dermoscopic images) vs usual care (a written referral letter) for specialist dermatologist review of a suspected skin cancer. MAIN OUTCOMES AND MEASURES: Cost and time in days to clinical resolution, where clinical resolution was defined as diagnosis by a dermatologist or excision by a general practitioner. Probabilistic sensitivity analysis was performed to examine the uncertainty of the main results. RESULTS: Findings from the decision-analytic model showed that the mean time to clinical resolution was 9 days (range, 1-50 days) with teledermoscopy referral compared with 35 days (range, 0-138 days) with usual care alone (difference, 26 days; 95% credible interval [CrI], 13-38 days). The estimated mean cost difference between teledermoscopy referral (A$318.39) vs usual care (A$263.75) was A$54.64 (95% CrI, A$22.69-A$97.35) per person. The incremental cost per day saved to clinical resolution was A$2.10 (95% CrI, A$0.87-A$5.29). CONCLUSIONS AND RELEVANCE: Using teledermoscopy for skin cancer referral and triage in Australia would cost A$54.64 extra per case on average but would result in clinical resolution 26 days sooner than usual care. Implementation recommendations depend on the preferences of the Australian health system decision makers for either lower cost or expedited clinical resolution. Further research around the clinical significance of expedited clinical resolution and its importance for patients could inform implementation recommendations for the Australian setting.
引用
- Snoswell CL, Caffery LJ, Whitty JA, et al. Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia. JAMA Dermatol. 2018. PMID: 29801161. doi:10.1001/jamadermatol.2018.0855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。